相关实验视频

Updated: Sep 10, 2025

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

基于SERS和SEIRA的高度选择性的布拉迪基宁B2受体对手的表征和检测

Edyta Proniewicz¹, Adam Prahl²

¹Faculty of Foundry Engineering, AGH University of Krakow, 30-059 Krakow, Poland.

International journal of molecular sciences

|August 28, 2025

概括

表面增强的拉曼光谱 (SERS) 和表面增强的红外光谱 (SEIRA) 使用银和金纳米粒子传感器检测布拉迪基宁对手. SERS提供了更高的选择性,金纳米粒子传感器对于个别检测更具特异性.

科学领域:

生物物理化学
光谱学
纳米技术

背景情况:

检测未标记的神经递质对于诊断癌症和神经退行性疾病至关重要.
表面增强拉曼光谱 (SERS) 和表面增强红外光谱 (SEIRA) 是用于分子指纹的非破坏性技术.
之前的研究尚未公布布布拉迪基宁 (BK) 或其类型的SEIRA光谱.

研究的目的:

调查SERS和SEIRA用于检测强烈的布拉迪基宁 (BK) 抗剂.
评估银 (AgNPs) 和金 (AuNPs) 纳米粒子传感器用于固定和检测的性能.
将SERS和SEIRA方法的选择性和特异性进行比较,以区分BK抗剂.

主要方法:

用于固定的一致AgNP和AuNP传感器的合成.
应用SERS和SEIRA技术来分析BK抗剂的振动结构.
与AgNP和AuNP表面的相互作用的比较分析.

主要成果:

两种AgNP和AuNP传感器都成功检测了研究中的BK抗体.
与SEIRA相比,SERS具有更高的选择性,可以通过增强的光谱带来化.
与AuNP表现出独特的相互作用,而与AgNP的结合通过C端发生在各种方向,使AuNP传感器更有选择性.

结论:

基于AgNP和AuNP纳米粒子的传感器可以有效地使用SERS和SEIRA检测BK抗剂.
在特定的结构之间区分,SERS提供了优越的选择性.
由于独特的相互作用,AuNP传感器具有更高的选择性,可识别单个的特定标记带.

关键词:

美国美国其他国家布拉迪基宁受体对抗剂表面增强的拉曼光谱表面增强的红外光谱

更多相关视频

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

Surface Enhanced Raman Spectroscopy Detection of Biomolecules Using EBL Fabricated Nanostructured Substrates

Surface Enhanced Raman Spectroscopy Detection of Biomolecules Using EBL Fabricated Nanostructured Substrates

Published on: March 20, 2015

相关概念视频

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...

Antihypertensive Drugs: Angiotensin II Receptor Blockers

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...